Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.68 |
| ▸ | HPGD | P15428 | 3/20 | 0.68 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.68 |
| ▸ | GAA | P10253 | 1/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.68 |
| ▸ | CTRC | Q99895 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | THRB | P10828 | 2/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | SIRT2 | Q8IXJ6 | 4/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9223130 | 1.00 | ALDH1A1 (0.68) | ALDH1A1HPGDALDH2GAAHSD17B10 | |
| SCHEMBL12200287 | 1.00 | ALDH1A1 (0.68) | ALDH1A1HPGDALDH2GAAHSD17B10 | |
| SCHEMBL14852665 | 1.00 | ALDH1A1 (0.68) | ALDH1A1HPGDALDH2GAAHSD17B10 | |
| SCHEMBL13236779 | 0.87 | ALDH1A1 (0.69) | ALDH1A1HPGDALDH2GAAHSD17B10 | |
| SCHEMBL13236778 | 0.83 | ALDH1A1 (0.75) | ALDH1A1HPGDALDH2MEN1MAPT | |
| SCHEMBL10824780 | 0.83 | CTRB1 (0.56) | ALDH1A1HPGDALDH2GAAHSD17B10 | |
| SCHEMBL13194998 | 0.81 | ALDH1A1 (0.79) | ALDH1A1HPGDALDH2GAAHSD17B10 | |
| SCHEMBL4878921 | 0.81 | ALDH1A1 (1.00) | ALDH1A1HPGDALDH2GAAHSD17B10 | |
| SCHEMBL9228116 | 0.81 | ALDH1A1 (0.70) | ALDH1A1HPGDALDH2GAAHSD17B10 | |
| SCHEMBL12856664 | 0.81 | ALDH1A1 (0.70) | ALDH1A1HPGDALDH2GAAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10561666-B2 | Amido compounds as RORγt modulators and uses thereof | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2020-02-18 | — | — | US | disclosed |
| US-9765063-B2 | Amido compounds as RORγt modulators and uses thereof | NEW YORK UNIVERSITY (US) | 2017-09-19 | — | — | US | disclosed |
| US-9765063-B2 | Amido compounds as RORγt modulators and uses thereof | NEW YORK UNIVERSITY (US) | 2017-09-19 | — | — | US | disclosed |
| US-20170065606-A1 | AMIDO COMPOUNDS AS RORyt MODULATORS AND USES THEREOF | NEW YORK UNIVERSITY | 2017-03-09 | — | — | US | disclosed |
| US-20170065606-A1 | AMIDO COMPOUNDS AS RORyt MODULATORS AND USES THEREOF | NEW YORK UNIVERSITY | 2017-03-09 | — | — | US | disclosed |
| US-9518076-B2 | Apparatus and process for preparing reactive lignin with high yield from plant biomass for production of fuels and chemicals | WASHINGTON STATE UNIVERSITY (US) | 2016-12-13 | — | — | US | disclosed |
| US-9492439-B2 | Amido compounds as RORγt modulators and uses thereof | NEW YORK UNIVERSITY (US) | 2016-11-15 | — | — | US | disclosed |
| US-9309215-B2 | Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof | UCB PHARMA GMBH (DE) | 2016-04-12 | — | — | US | disclosed |
| US-20150099868-A1 | APPARATUS AND PROCESS FOR PREPARING REACTIVE LIGNIN WITH HIGH YIELD FROM PLANT BIOMASS FOR PRODUCTION OF FUELS AND CHEMICALS | WASHINGTON STATE UNIVERSITY (US) | 2015-04-09 | — | — | US | disclosed |
| US-20150057278-A1 | AMIDO COMPOUNDS AS RORyT MODULATORS AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-02-26 | — | — | US | disclosed |
| US-20140228434-A1 | CHIRAL INTERMEDIATE, PROCESS FOR PRODUCING THE SAME AND ITS USE IN THE MANUFACTURE OF TOLTERODINE, FESOTERODINE, OR THE ACTIVE METABOLITE THEREOF | UCB PHARMA GMBH (DE) | 2014-08-14 | — | — | US | disclosed |
| US-8742140-B2 | Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof | UCB PHARMA GMBH (DE) | 2014-06-03 | — | — | US | disclosed |
| US-20130085162-A1 | AMIDO COMPOUNDS AS RORyT MODULATORS AND USES THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2013-04-04 | — | — | US | disclosed |
| US-20110245338-A1 | CHIRAL INTERMEDIATE, PROCESS FOR PRODUCING THE SAME AND ITS USE IN THE MANUFACTURE OF TOLTERODINE, FESOTERODINE, OR THE ACTIVE METABOLITE THEREOF | UCB PHARMA GMBH (DE) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099868-A1 | APPARATUS AND PROCESS FOR PREPARING REACTIVE LIGNIN WITH HIGH YIELD FROM PLANT BIOMASS FOR PRODUCTION OF FUELS AND CHEMICALS | HAAO, HAO2, HAO1 | ALDH1A1 1709/4885HPGD 108/4885ALDH2 1000/4885 |
| US-20110245338-A1 | CHIRAL INTERMEDIATE, PROCESS FOR PRODUCING THE SAME AND ITS USE IN THE MANUFACTURE OF TOLTERODINE, FESOTERODINE, OR THE ACTIVE METABOLITE THEREOF | CYP1B1, NISCH, HSD17B7 | ALDH1A1 780/4885HPGD 498/4885ALDH2 1270/4885 |
| US-10561666-B2 | Amido compounds as RORγt modulators and uses thereof | RORB, RORA, RORC | ALDH1A1 1130/4885HPGD 1073/4885ALDH2 2070/4885 |
| US-20170065606-A1 | AMIDO COMPOUNDS AS RORyt MODULATORS AND USES THEREOF | RORB, RORA, RORC | ALDH1A1 1551/4885HPGD 2100/4885ALDH2 2489/4885 |
| US-20150057278-A1 | AMIDO COMPOUNDS AS RORyT MODULATORS AND USES THEREOF | RORB, RORA, RORC | ALDH1A1 2099/4885HPGD 1214/4885ALDH2 2382/4885 |
| US-20140228434-A1 | CHIRAL INTERMEDIATE, PROCESS FOR PRODUCING THE SAME AND ITS USE IN THE MANUFACTURE OF TOLTERODINE, FESOTERODINE, OR THE ACTIVE METABOLITE THEREOF | CYP1B1, NISCH, HSD17B7 | ALDH1A1 780/4885HPGD 498/4885ALDH2 1270/4885 |
| US-20130085162-A1 | AMIDO COMPOUNDS AS RORyT MODULATORS AND USES THEREOF | RORB, RORA, RORC | ALDH1A1 1551/4885HPGD 2100/4885ALDH2 2489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.